Response

J Natl Cancer Inst. 2016 Feb 24;108(3):djw001. doi: 10.1093/jnci/djw001. Print 2016 Mar.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biomarkers, Tumor*
  • Drug Approval*
  • Humans
  • Molecular Targeted Therapy*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor